Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

John E. Baker PhD
Professor
Department of Surgery
Division of Pediatric Congenital Cardiac Surgery

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
1973 - 1977 The Polytechnic, Wolverhampton, West Midlands, Degree: B.Sc.(Honors)
1977 - 1984 Department of Biochemistry, Degree: Ph.D.
St. Thomas' Hospital Medical School, London (Supervisor: Professor David J. Hearse)

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1977 - 1978 Senior Biochemist, Central Pathology Laboratories, Harley Street, London
1978 - 1984 Research Assistant, Department of Biochemistry, St. Thomas' Hospital Medical School, London
1984 - 1986 Postdoctoral Fellow of Cardiothoracic Surgery, The Medical College of Wisconsin, Milwaukee, Wisconsin

FACULTY APPOINTMENTS:
1986 - 1987 Visiting Professor of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
1987 - 1992 Assistant Professor of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
1987 - 1997 Assistant Professor of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin
1992 - 1999 Assistant Professor of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
1992 - 1999 Associate Professor of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
1997 - 2001 Associate Professor of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin
1999 - 2001 Associate Professor of Pediatric Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
1999 - 2001 Associate Professor of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
2001 - 2007 Professor of Pediatric Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
2001 - Present , Professor of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin
2001 - Present , Professor of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
2007 - Present , Professor of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Book Chapters
2. Baker JE and Hearse DJ: Differing Potencies and Dose-Response Characteris¬tics in the Ability of Slow Calcium Channel Blockers to Reduce Enzyme Leakage in the Calcium Paradox. Advances in Myocardiology 6:637-646, 1985
3. Baker JE, Felix CC, Olinger GN, and Kalyanaraman B: Electron Spin Resonance Spectroscopy Provides Direct Evidence for Free Radical Generation During Myocardial Ischemia and Reperfusion. In "Free Radicals: Methodology and Concepts". Eds., Rice-Evans and Halliwell. Richelieu Press. 185-189, 1988
4. Baker JE, Kalyanaraman B, and Felix CC: Detection of Free Radicals by Direct ESR During Myocardial Cell Injury - A Critical Evaluation. In "Oxy-Radicals in Molecular Biology and Pathology". Eds., Cerutti, Fridovich and McCord. Alan R. Liss. 343-351, 1988
5. Baker JE. Pathophysiology of Reperfusion-Induced Injury in the Immature Heart During Cardiac Surgery. In "Pathophysiology of Reperfusion Injury" Ed. D.K. Das. CRC Press. Boca Raton 295-323, 1992
6. Kalyanaraman B, Konorev EA, Joseph J, Baker JE: Radical Generation and Detection in Myocardial Injury. In "Free Radical Damage and Its Control" Eds., CA Rice-Evans and RH Burton. Elsevier Science pp 329-355, 1994
7. Kalyanaraman B, Konorev EA, Joseph J, Baker JE. A Critical Review of Myocardial Protection by Spin Traps. In "Free Radicals in the Environment, Medicine, and Toxicology" Eds., H Nohl, H Esterbauer, CA Rice-Evans. Richelieu Press, pp 313-326, 1994
8. Baker JE, Horn JB, Nikolaychik V, Kipshidze NN. Fibrin Stent Coatings. In: "Endoluminal Stenting" Ed. Ulrich Sigwart, W. B. Saunders pp 84-89, 1996
9. Kipshidze NN, Horn JB, Nikolaychik V, Baker JE. Novel Method of Sealing of Entry Sites Following Endovascular Procedures. In: "Endoluminal Stenting" Ed. Ulrich Sigwart, W. B. Saunders pp 328-331, 1996
10. Maulik N, Baker JE, Engelman RM, Das DK. Postnatal Development Profiles of Antioxidant Enzymes in Heart. In: "Myocardial preservation, preconditioning, and adaptation" Eds. Das DK, Engelman R, Cherian KM. Annals of New York Acad Sci 793:439-448, 1996
11. Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA Jr. Adaptation to Chronic Hypoxia Confers Tolerance to Subsequent Myocardial Ischemia by Increased Nitric Oxide Production. In: "Heart in Stress" Eds. Das DK. Ann New York Acad Sci 874:236-253, 1999
12. Rafiee,P, Shi Y, Pritchard Jr KA, Tweddell JS, Baker JE. Activation of protein kinases and cellular redistribution of inducible hsp90 protein in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. In: Adaptation Biology and Medicine", Vol 4: Current Concepts, 2005
13. Cabigas BP, Baker JE. Nitric oxide synthase 3 mediates cardioprotection by hyperoxia and hyperbaria. In: "Adaptation Biology and Medicine", Vol 5, 2006
14. Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, Migrino RQ, Doppalapudi A, Harmann L, Li A, Hopewell JW, Moulder JE. 10 GY Total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. In: "Adaptation Biology and Medicine", Vol 6, 143-159, 2011
15. Papers
16. Hearse DJ and Baker JE: Verapamil and the Calcium Paradox: A Reaffirma¬tion. J Mol Cell Cardiol 13:1087-1089, 1981
17. Baker JE, Bullock GR, and Hearse DJ: The Temperature Dependence of the Calcium Paradox: Enzymatic, Functional and Morphological Correlates of Cellular Injury. J Mol Cell Cardiol 15:393-411, 1983
18. Baker JE, and Hearse DJ: Slow Channel Calcium Blockers and the Calcium Paradox: Comparative Studies in the Rat with Seven Drugs. J Mol Cell Cardiol 15:475-485, 1983
19. Baker JE, and Hearse DJ: The Temperature-Sensitivity of Slow Channel Calcium Blockers in Relation to Their Effect Upon the Calcium Paradox. Eur Heart J 4 (Suppl. 4):97-103, 1983
20. Baker JE, Kemmenoe BH, Hearse DJ, and Bullock GR: Calcium Delivery and Time: Factors Affecting the Progression of Cellular Damage During the Calcium Paradox in the Rat Heart. Cardiovasc Res 18:361-370, 1984
21. Baker JE: The Calcium Paradox: Its Characterization and Possible Mechanisms in the Rat Heart. Ph.D. Thesis. University of London 1984.
22. Baker JE, Boerboom LE, Olinger GN: Age-Related Changes in Myocardial Protection of the Isolated Rabbit Heart. Surg Forum 37:293-295, 1986
23. Baker JE, Felix CC, Olinger GN, and Kalyanaraman B: Myocardial Ischemia and Reperfusion: Direct Evidence for Free Radical Generation by Electron Spin Resonance Spectroscopy. Proc Natl Acad Sci (USA) 85:2786-2789, 1988
24. Baker JE, Boerboom LE and Olinger GN: Age-Related Changes in the Ability of Hypothermia and Cardioplegia to Protect Ischemic Rabbit Myocardium. J Thorac Cardiovasc Surg 96:717-724, 1988
25. Eskinder H, Hillard CJ, Olinger GN, Christensen CW, Baker JE, Warltier DC, and Gross GG: Alpha Adrenoceptor Subtypes and Receptor Reserve in Human Versus Canine Saphenous Vein: Sensitivity to Blockade by Nitroglycerin. J Pharmacol Exp Ther 247:941-948, 1988
26. Baker JE, and Kalyanaraman B: Ischemia-Induced Changes in Myocardial Paramagnetic Metabolites: Implications for Intracellular Oxy-Radical Generation. FEBS Letters 244:311-314, 1989
27. Baker JE, Boerboom LE, and Olinger GN: Is Protection of Ischemic Neonatal Myocardium by Cardioplegia Species Dependent? J Thorac Cardiovasc Surg 99:280-287, 1990
28. Kalyanaraman B, and Baker JE: On the Detection of Paramagnetic Species in the Adriamycin-perfused Rat Heart: A Reappraisal. Biochem Biophys Res Comm 169:30-38, 1990
29. Baker JE, Boerboom LE and Olinger GN: Cardioplegia-Induced Damage to Ischemic Immature Heart is Independent of Oxygen Availability. Ann Thorac Surg 50:934-939, 1990
30. Baker EJ, Olinger GN, Baker JE: Calcium Content of St. Thomas' II Cardioplegic Solution Damages Ischemic Immature Myocardium. Ann Thorac Surg 52:993-999, 1991
31. Baker JE, Boerboom LE, Olinger GN: Age and Protection of the Ischemic Myocardium: Is Alkaline Cardioplegia Appropriate? Ann Thorac Surg 55:747-755, 1993
32. Konorev EA, Baker JE, Joseph J, Kalyanaraman B: Vasodilatory and Toxic Effects of Spin Traps on Aerobic Cardiac Function. Free Rad Med Biol 14:127-137, 1993
33. Baker JE, Olinger GN, Boerboom LE: Protection of the Ischemic Immature Heart - Effect of Perfusate Reinfusion and Composition. Thorac Cardiovasc Surg 41:274-279, 1993
34. Baker JE. Recovery of Hypoxic Neonatal Hearts After Cardioplegic Arrest. Cardiovasc Res 27:1135-1136, 1993
35. Konorev EA, Struck AT, Baker JE, Ramanujam S, Thomas JP, Radi R, Kalyanaraman B: Intracellular Catalase Inhibition Does Not Predispose Rat Heart to Ischemia-Reperfusion-and Hydrogen Peroxide-Induced Injuries. Free Rad Res Commun 19:397-407, 1993
36. Baker JE, Konorev EA, Tse SYH, Joseph J, Kalyanaraman B: Lack of Protection of PBN in Isolated Rat Heart During Ischemia and Reperfusion: Implications for Hydroxyl Radical Generation. Free Rad Res Commun 20:145-163, 1994
37. Baker EJ, Baker JE. Calcium and Cardioplegic Protection of the Ischemic Immature Heart: Impact of Hypoxemia From Birth. Ann Thorac Surg 58:1123-1130, 1994
38. Baker EJ, Boerboom LE, Olinger GN, Baker JE: Tolerance of the Developing Heart to Ischemia: Impact of Hypoxemia from Birth. Am J Physiol 268:H1165-H1173, 1995
39. Palmisano BW, Mehner RW, Baker JE, Stowe DF, Bosnjak ZJ, Kampine JP. Direct Effects of Halothane and Isoflurane in Infant Rabbit Hearts with Right Ventricular Hypertrophy Secondary to Chronic Hypoxemia. Anesth Analg 80:1122-1128, 1995
40. Konorev EA, Tarpey M, Joseph J, Baker JE, Kalyanaraman B. Nitronyl Nitroxides as Probes to Study the Mechanism of Vasodilatory Action of Nitrovasodilators, Nitrone Spin Traps and Nitroxides - Role of Nitric Oxide. Free Rad Biol Med 18:169-177, 1995
41. Konorev EA, Joseph J, Tarpey MM, Baker JE, Kalyanaraman B. S-Nitrosoglutathione Improves Functional Recovery in the Isolated Rat Heart Following Cardioplegic Ischemic Arrest-Evidence for a Cardioprotective Effect of Nitric Oxide. J Pharmacol Exp Ther 274:200-206, 1995
42. Kalyanaraman B, Konorev EA, Joseph J, Baker JE. Is Free Radical Generation an Important Component of Ischemia/Reperfusion Injury? Part 2. Redox Report 1:181-184, 1995
43. Baker JE, Froncisz W, Joseph J, Kalyanaraman B: Spin Label Oximetry to Assess Extracellular Oxygen During Myocardial Ischemia. Free Rad Med Biol 22:109-115, 1997
44. Baker JE, Curry BD, Olinger GN, Gross GJ. Increased Tolerance of the Chronically Hypoxic Immature Heart to Ischemia: Contribution of the KATP Channel. Circulation 95:1278-1285, 1997
45. Raff H, Jankowski BM, Goodfriend TL, Baker JE, Papanek PE. The Effect of Exposure to Hypoxia From Birth on Aldosterone in Rabbits: Role of Unesterified Fatty Acids. Am J Physiol:Regulatory, Integrative and Comparative Physiology 272:R1084-R1087, 1997
46. Baker JE, Contney SJ, Gross GJ, Bosnjak ZJ. KATP Channel Activation in a Rabbit Model of Chronic Myocardial Hypoxia. J Moll Cell Cardiol 29:845-848, 1997
47. Baker JE, Olinger GN. Myocardial Protection of the Hypoxic Heart. J Thorac Cardiovasc Surg 113:1123-1124, 1997
48. Baker JE, Holman P, Kalyanaraman B, Pritchard KA Jr. Adaptation of hearts to chronic hypoxia increases tolerance to subsequent ischemia by increased nitric oxide production. Adv Exp Med Biol. 454:203 17, 1998
49. Baker JE, Holman P, Gross GJ. Preconditioning in Immature Rabbit Hearts: Role of KATP Channels. Circulation 99: 1249-1254, 1999
50. Baker JE, Konorev EA, Gross GJ, Chilian WM, Jacob HJ. Resistance to Myocardial Ischemia in Five Rat Strains: Is There a Genetic Component of Cardioprotection? Am J Physiol:Heart Circulat Physiol 278: H1395-H1400, 2000
51. Shi Y, Pritchard Jr., KA, Holman P, Rafiee P, Griffith OW, Kalyanaraman B, Baker JE. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Radic Biol Med 29:695-703, 2000
52. Eells JT, Henry MM, Gross GJ, Baker JE. Increased Mitochondrial KATP Channel Activity During Chronic Myocardial Hypoxia: Is Cardioprotection Mediated by Improved Bioenergetics? Circ Res 87:915-921, 2000
53. Baker JE, Contney SJ, Singh R, Kalyanaraman B, Gross GJ, Bosnjak ZJ. Nitric Oxide Activates the Sarcolemmal KATP Channel in Normoxic and Chronically Hypoxic Hearts by a Cyclic GMP Dependent Mechanism. J Mol Cell Cardiol 33:331-341, 2001
54. Pritchard Jr KA, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276:17621-17624, 2001
55. Kong X, Tweddell JS, Gross GJ, Baker JE. Sarcolemmal and mitochondrial KATP channels mediate cardioprotection in chronically hypoxic hearts. J Mol Cell Cardiol 33:1041-1045, 2001
56. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, Tweddell JS, Fitzpatrick CM, Baker JE. Delayed cardioprotection by isoflurane: role of KATP channels. Am J Physiol:Heart Circulat Physiol 283:H61-H68, 2002
57. Rafiee P, Shi Y, Kong X, Pritchard KA, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Su J, Baker JE. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation 106:239-245, 2002
58. Shi Y, Baker JE, Zhang C, Tweddell JS, Su J, Pritchard Jr. KA. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 and serine phosphorylation. Circ Res 91:300-306, 2002
59. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, Jacobs ER. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 92:992-1000, 2003
60. Rafiee P, Shi Y, Pritchard, Jr. KA, Ogawa H, Eis ALW, Komorowski RA, Fitzpatrick CM, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Baker JE. Cellular redistribution of inducible Hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia: Role of protein kinases. J Biol Chem 278:43636-43644, 2003
61. Shi Y, Rafiee P, Su J, Pritchard Jr KA, Tweddell JS, Baker JE. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 99:173-182, 2004
62. Baker JE. Oxidative stress and adaptation of the infant heart to hypoxia and ischemia. Antioxidants & Redox Signaling 6:423-429, 2004
63. Fitzpatrick CM, Shi Y, Hutchins WC, Su J, Gross GJ, Ostadal B, Tweddell JS, Baker JE. Cardioprotection In chronically hypoxic rabbits persists upon exposure to normoxia: Role of nitric oxide synthase and KATP channels. Am J Physiol 288:H62-H68, 2005.
64. Shi Y, Hutchins WC, Su J, Siker D, Hogg N, Pritchard Jr. KA, Keszler A, Tweddell JS, Baker JE. Delayed cardioprotection with isoflurane: role of reactive oxygen and nitrogen. Am J Physiol 288:H175-H184, 2005
65. Rafiee P, Shi Y, Su J, Pritchard Jr. KA, Tweddell JS, Baker JE. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100:187-197, 2005
66. Shi Y, Hutchins W, Ogawa H, Chang C-C, Pritchard Jr. KA, Zhang C, Khampang P, Lazar J, Jacob HJ, Rafiee P, Baker JE. Increased Resistance to Myocardial Ischemia in the Brown Norway vs. Dahl S Rat: Role of Nitric Oxide Synthase and Hsp90. J Mol Cell Cardiol 38:625-635, 2005
67. Baker JE. Erythropoietin mimics ischemic preconditioning. In special issue on "Mechanisms of Drug-Induced Cardiac Preconditioning." Vascular Pharmacology 42:233-241, 2005
68. Nilakantan, V.; Zhou, X.; Hilton, G.; Shi, Y.; Baker, J. E.; Khanna, A. K.; Pieper, G. M. Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J Thorac Cardiovasc Surg 131:898-906; 2006
69. Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS, Kunert MP, Lombard JH, Mattson DL, Pritchard Jr KA, Roman RJ, Tonellato PJ, Cowley Jr AW. The BN phenome: Detailed characterization of the cardiovascular, renal and pulmonary systems of the sequenced rat. Physiol Genomics 25:202213; 2006
70. Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, Nilakantan V, Kindwall E, Niezgoda JA, Baker JE. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 72:143-51, 2006
71. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. SCH 79797, a selective PAR-1 antagonist, limits myocardial ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 102:350-358, 2007
72. Baker JE, Kozik D, Hsu AK, Fu X, Tweddell JS, Gross GJ. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action and mechanisms. J Cardiovasc Pharmacol 49:337-345, 2007
73. Shi Y, Jiang MT, Su J, Hutchins W, Konorev E, Baker JE. Mitochondrial big conductance KCa channel and cardioprotection in infant rabbit heart. J Cardiovasc Pharmacol 50:497-502, 2007
74. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and KATP channels. J Mol Cell Cardiol 43:437-444, 2007
75. Nicolosi AC, Strande JL, Hsu A, Fu X, Su J, Gross GJ, Baker JE. Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms. J Mol Cell Cardiol 44:345-351, 2008
76. Baker JE, Su J, Hsu A, Shi Y, Zhao M, Xu H, Eis A, Komorowski R, Wang J, Fu X, Konorev E, Jensen ES, Tweddell JS, Gross GJ. Human thrombopoietin reduces myocardial infarct size, apoptosis and stunning following ischemia/reperfusion in rats. Cardiovasc Res 77:44-53, 2008
77. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther 324:1045-1054, 2008
78. Aggarwal NT, Pfister SL, Gauthier KM, Chawengsub Y, Baker, JE. Chronic hypoxia enhances 15-lipoxygenase mediated vasorelaxation in rabbit arteries. Am J Physiol Heart Circ Physiol 296: H678-88, 2009
79. Strande JL, Widlansky ME, Tsopanoglou NE, Su J, Wang J, Hsu A, Routhu KV, Baker JE. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. Cardiovasc Res 83: 325-34, 2009
80. Veldkamp CT, Ziarek J, Jidong S, Basnet H, Lennertz R, Weiner J, Peterson FC, Baker JE, Volkman BF. Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Science 18: 1359-1369, 2009
81. Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, Migrino RQ, Doppalapudi A, Harmann L, Li XA, Hopewell JW, Moulder JE. 10 GY Total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 85: 1089-100, 2009
82. Strande JL, Routhu KV, Hsu A, Nicolosi AC, Baker JE. Gadolinium decreases inflammation related to myocardial ischemia and reperfusion injury. J Inflamm 6: 34, 2009
83. Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, & Nithipatikom K. Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. Am J Physiol Heart Circ Physiol 298: H2201-2207, 2010
84. Baker JE, Moulder JE, Hopewell JW. Radiation as a risk factor for cardiovascular disease. Antioxidant & Redox Signaling 15:1945-56, 2011
85. Jourdan MM, Lopez A, Olasz EB, Duncan NE, Demara M, Kittipongdaja W, Fish BL, Mader M, Schock A, Morrow NV, SemenenkoV, Baker JE, Moulder JE, Lazarova Z. Laminin 332 Deposition is Diminished in Irradiated Skin in an Animal Model of Combined Radiation and Wound Skin Injury. Radiat Res. 176:636-48, 2011
86. Gross GJ, Baker JE, Moore J, Falck JR, & Nithipatikom K.. Abdominal Surgical Incision Induces Remote Preconditioning of Trauma (RPCT) via Activation of Bradykinin Receptors (BK2R) and the Cytochrome P450 Epoxygenase Pathway in Canine Hearts. Cardiovasc Drugs Ther. 5:517-22, 2011
87. Lam V, Moulder JE, Salzman NH, Dubinsky EA, Andersen GL, Baker, JE. Intestinal microbiota as novel biomarkers of prior radiation exposure. Radiat Res 177:573-583, 2012
88. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 26:1727-35, 2012
89. Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF. Heparin oligosaccharides inhibit chemokine (CXC Motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J Biol Chem. 4;288(1):737-46, 2013
90. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. Response to ‘Letter to the Editor’ FASEB J 2012. (In Press )
 

jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a